<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Manrique-Saide P</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>Innovative Vector Control Consortium</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>839</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7542575</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Current urban vector control strategies have failed to contain dengue epidemics and to prevent the global expansion of Aedes-borne viruses (ABVs: dengue, chikungunya, Zika). Part of the challenge in sustaining effective ABV control emerges from the paucity of evidence regarding the epidemiological impact of any Aedes control method. A strategy for which there is limited epidemiological evidence is targeted indoor residual spraying (TIRS). TIRS is a modification of classic malaria indoor residual spraying that accounts for Aedes aegypti resting behavior by applying residual insecticides on exposed lower sections of walls (&lt; 1.5 m), under furniture, and on dark surfaces.&lt;h4>Methods/design&lt;/h4>We are pursuing a two-arm, parallel, unblinded, cluster randomized controlled tri</pubmed_abstract><journal>Trials</journal><pubmed_title>The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico.</pubmed_title><pmcid>PMC7542575</pmcid><funding_grant_id>U01 AI148069</funding_grant_id><funding_grant_id>R37 AI0032042</funding_grant_id><funding_grant_id>U54 GM111274</funding_grant_id><funding_grant_id>U01AI148069</funding_grant_id><funding_grant_id>R37 AI032042</funding_grant_id><funding_grant_id>DFID:30041-105</funding_grant_id><funding_grant_id>R01 AI139761</funding_grant_id><pubmed_authors>Dean NE</pubmed_authors><pubmed_authors>Halloran ME</pubmed_authors><pubmed_authors>Kirstein OD</pubmed_authors><pubmed_authors>Perez PG</pubmed_authors><pubmed_authors>Pavia-Ruz N</pubmed_authors><pubmed_authors>Gomez-Dantes H</pubmed_authors><pubmed_authors>Hladish TJ</pubmed_authors><pubmed_authors>Lenhart A</pubmed_authors><pubmed_authors>Ayora-Talavera G</pubmed_authors><pubmed_authors>Mendez-Vales R</pubmed_authors><pubmed_authors>Collins MH</pubmed_authors><pubmed_authors>Romer Y</pubmed_authors><pubmed_authors>Manrique-Saide P</pubmed_authors><pubmed_authors>Che-Mendoza A</pubmed_authors><pubmed_authors>Correa-Morales F</pubmed_authors><pubmed_authors>Longini IM</pubmed_authors><pubmed_authors>Palacio-Vargas J</pubmed_authors><pubmed_authors>Vazquez-Prokopec GM</pubmed_authors><pubmed_authors>Waller LA</pubmed_authors></additional><is_claimable>false</is_claimable><name>The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico.</name><description>&lt;h4>Background&lt;/h4>Current urban vector control strategies have failed to contain dengue epidemics and to prevent the global expansion of Aedes-borne viruses (ABVs: dengue, chikungunya, Zika). Part of the challenge in sustaining effective ABV control emerges from the paucity of evidence regarding the epidemiological impact of any Aedes control method. A strategy for which there is limited epidemiological evidence is targeted indoor residual spraying (TIRS). TIRS is a modification of classic malaria indoor residual spraying that accounts for Aedes aegypti resting behavior by applying residual insecticides on exposed lower sections of walls (&lt; 1.5 m), under furniture, and on dark surfaces.&lt;h4>Methods/design&lt;/h4>We are pursuing a two-arm, parallel, unblinded, cluster randomized controlled tri</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2026-05-01T00:31:02.825Z</modification><creation>2020-10-29T09:31:59Z</creation></dates><accession>S-EPMC7542575</accession><cross_references><pubmed>33032661</pubmed><doi>10.1186/s13063-020-04780-7</doi></cross_references></HashMap>